Melanoma T-cell treatment found more effective than competitor’s drug

A skin cancer cell-based therapy showed stronger results than the leading immunotherapy melanoma drug, ipilimumab, in a phase 3 trial conducted by the Netherlands Cancer Institute. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive